Compare MCFT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCFT | CCCC |
|---|---|---|
| Founded | 1968 | 2015 |
| Country | United States | United States |
| Employees | 1400 | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 477.1M | 404.7M |
| IPO Year | 2015 | 2020 |
| Metric | MCFT | CCCC |
|---|---|---|
| Price | $20.72 | $3.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | ★ $24.25 | $12.20 |
| AVG Volume (30 Days) | 265.4K | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.45 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $348,903,000.00 | $35,947,000.00 |
| Revenue This Year | $9.18 | N/A |
| Revenue Next Year | $8.23 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.77 | 1.02 |
| 52 Week Low | $17.19 | $1.69 |
| 52 Week High | $28.44 | $5.17 |
| Indicator | MCFT | CCCC |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | 27.04 |
| Support Level | $19.13 | $2.52 |
| Resistance Level | $20.78 | $3.20 |
| Average True Range (ATR) | 1.07 | 0.17 |
| MACD | 0.04 | -0.05 |
| Stochastic Oscillator | 29.26 | 16.37 |
MasterCraft Boat Holdings Inc is a designer, manufacturer, and marketer of recreational powerboats sold through five brands: MasterCraft, Crest, Balise, Chaparral, and Robalo. It manufactures and sells recreational inboard, outboard, and sterndrive boats that it believes delivers superior performance for water skiing, wakeboarding, wakesurfing, and fishing, as well as general recreational boating. In addition, it offers various accessories, including trailers and aftermarket parts. Its segments are the Performance and Wake segment, consisting of the MasterCraft brand, which produces boats at its Vonore, Tennessee facility; The Leisure segment, consisting of Crest and Balise brands, which produces pontoon boats at its Owosso, Michigan facility; and the Recreation and Sport Fishing segment.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.